| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 26 | 2024 | 655 | 4.070 |
Why?
|
| Critical Illness | 17 | 2024 | 618 | 3.290 |
Why?
|
| Deglutition Disorders | 8 | 2022 | 145 | 3.280 |
Why?
|
| Speech | 17 | 2025 | 77 | 2.980 |
Why?
|
| Wounds and Injuries | 11 | 2024 | 393 | 2.600 |
Why?
|
| Wounds, Nonpenetrating | 11 | 2025 | 221 | 2.410 |
Why?
|
| Abdominal Injuries | 10 | 2025 | 117 | 2.370 |
Why?
|
| Bile Duct Neoplasms | 4 | 2024 | 124 | 2.340 |
Why?
|
| Cholangiocarcinoma | 4 | 2024 | 123 | 2.340 |
Why?
|
| Blood Transfusion | 7 | 2023 | 291 | 2.310 |
Why?
|
| Respiration, Artificial | 6 | 2023 | 504 | 2.170 |
Why?
|
| Critical Care | 13 | 2024 | 686 | 2.030 |
Why?
|
| Hemorrhage | 12 | 2024 | 519 | 1.990 |
Why?
|
| Deglutition | 7 | 2022 | 60 | 1.990 |
Why?
|
| Erythrocyte Transfusion | 11 | 2024 | 138 | 1.960 |
Why?
|
| Injury Severity Score | 16 | 2024 | 230 | 1.850 |
Why?
|
| Ataxia | 4 | 2024 | 177 | 1.790 |
Why?
|
| Child | 104 | 2025 | 25786 | 1.610 |
Why?
|
| Consensus | 12 | 2024 | 651 | 1.510 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 12 | 2024 | 426 | 1.490 |
Why?
|
| Tracheostomy | 3 | 2023 | 204 | 1.410 |
Why?
|
| Humans | 182 | 2025 | 132089 | 1.400 |
Why?
|
| Delirium | 2 | 2021 | 61 | 1.250 |
Why?
|
| Blood Coagulation Disorders | 3 | 2017 | 109 | 1.240 |
Why?
|
| Speech Disorders | 7 | 2025 | 48 | 1.240 |
Why?
|
| Resuscitation | 9 | 2024 | 270 | 1.220 |
Why?
|
| Dysarthria | 3 | 2023 | 26 | 1.200 |
Why?
|
| Intensive Care Units, Pediatric | 4 | 2020 | 466 | 1.170 |
Why?
|
| Retrospective Studies | 65 | 2025 | 17416 | 1.150 |
Why?
|
| Trauma Centers | 10 | 2025 | 199 | 1.100 |
Why?
|
| Communication | 6 | 2025 | 543 | 1.060 |
Why?
|
| Plasma | 7 | 2024 | 102 | 1.050 |
Why?
|
| Thrombelastography | 3 | 2017 | 63 | 0.990 |
Why?
|
| Biliary Tract Neoplasms | 2 | 2024 | 21 | 0.980 |
Why?
|
| Infant, Newborn | 38 | 2025 | 8549 | 0.980 |
Why?
|
| Adolescent | 53 | 2025 | 20560 | 0.940 |
Why?
|
| Shock, Hemorrhagic | 4 | 2022 | 55 | 0.940 |
Why?
|
| Child, Preschool | 49 | 2025 | 14749 | 0.930 |
Why?
|
| Stuttering | 5 | 2023 | 7 | 0.910 |
Why?
|
| Communication Disorders | 2 | 2024 | 10 | 0.860 |
Why?
|
| Singing | 2 | 2023 | 9 | 0.850 |
Why?
|
| Niemann-Pick Disease, Type C | 1 | 2023 | 4 | 0.850 |
Why?
|
| Brain Injuries, Traumatic | 4 | 2023 | 302 | 0.850 |
Why?
|
| Male | 84 | 2025 | 64967 | 0.830 |
Why?
|
| Infant | 50 | 2025 | 13061 | 0.820 |
Why?
|
| Friedreich Ataxia | 2 | 2022 | 48 | 0.810 |
Why?
|
| Hallucinogens | 2 | 2021 | 51 | 0.810 |
Why?
|
| Female | 86 | 2025 | 70695 | 0.800 |
Why?
|
| Medical Oncology | 4 | 2024 | 244 | 0.780 |
Why?
|
| Gallbladder Neoplasms | 1 | 2022 | 15 | 0.770 |
Why?
|
| Speech Acoustics | 4 | 2021 | 11 | 0.760 |
Why?
|
| Heparin | 1 | 2023 | 212 | 0.750 |
Why?
|
| Life Support Care | 2 | 2020 | 47 | 0.740 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 254 | 0.730 |
Why?
|
| Cannabis | 2 | 2021 | 49 | 0.720 |
Why?
|
| Hospital Mortality | 8 | 2023 | 1057 | 0.720 |
Why?
|
| Anemia | 6 | 2022 | 350 | 0.720 |
Why?
|
| Frontotemporal Dementia | 2 | 2025 | 71 | 0.710 |
Why?
|
| Speech Production Measurement | 5 | 2023 | 28 | 0.710 |
Why?
|
| Pancreas | 4 | 2024 | 222 | 0.700 |
Why?
|
| Pyrimidines | 1 | 2024 | 418 | 0.690 |
Why?
|
| Trisomy 13 Syndrome | 1 | 2020 | 19 | 0.670 |
Why?
|
| Homes for the Aged | 1 | 2020 | 22 | 0.670 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2020 | 16 | 0.670 |
Why?
|
| Quality of Life | 8 | 2022 | 2161 | 0.660 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2020 | 255 | 0.660 |
Why?
|
| Assisted Living Facilities | 1 | 2020 | 2 | 0.660 |
Why?
|
| Cineradiography | 1 | 2020 | 4 | 0.660 |
Why?
|
| Delphi Technique | 5 | 2024 | 241 | 0.650 |
Why?
|
| Neurological Rehabilitation | 1 | 2020 | 7 | 0.640 |
Why?
|
| Anticoagulants | 5 | 2024 | 609 | 0.640 |
Why?
|
| Voice | 1 | 2020 | 17 | 0.640 |
Why?
|
| Blood Coagulation Tests | 2 | 2023 | 61 | 0.630 |
Why?
|
| Quality Improvement | 5 | 2023 | 699 | 0.630 |
Why?
|
| Motor Neuron Disease | 1 | 2019 | 18 | 0.620 |
Why?
|
| Cognitive Dysfunction | 2 | 2025 | 317 | 0.620 |
Why?
|
| Pharynx | 1 | 2019 | 66 | 0.620 |
Why?
|
| Speech Perception | 2 | 2018 | 57 | 0.610 |
Why?
|
| Intensive Care Units | 2 | 2022 | 523 | 0.610 |
Why?
|
| Personal Satisfaction | 1 | 2020 | 106 | 0.600 |
Why?
|
| Femoral Artery | 1 | 2020 | 166 | 0.600 |
Why?
|
| Deep Sedation | 1 | 2019 | 7 | 0.600 |
Why?
|
| Child Abuse | 4 | 2023 | 204 | 0.590 |
Why?
|
| Mouth | 1 | 2019 | 67 | 0.590 |
Why?
|
| Sternum | 1 | 2019 | 53 | 0.590 |
Why?
|
| Language | 4 | 2025 | 226 | 0.590 |
Why?
|
| Endoscopy | 2 | 2020 | 289 | 0.590 |
Why?
|
| Analgesia | 1 | 2019 | 43 | 0.580 |
Why?
|
| Australia | 5 | 2022 | 185 | 0.580 |
Why?
|
| Conscious Sedation | 1 | 2019 | 60 | 0.580 |
Why?
|
| Physical Abuse | 4 | 2023 | 24 | 0.580 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2023 | 985 | 0.570 |
Why?
|
| Pediatrics | 5 | 2024 | 1213 | 0.570 |
Why?
|
| Pitch Perception | 1 | 2018 | 4 | 0.570 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 130 | 0.570 |
Why?
|
| Adult | 31 | 2025 | 31575 | 0.560 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2020 | 768 | 0.550 |
Why?
|
| Perioperative Care | 2 | 2024 | 211 | 0.550 |
Why?
|
| Glioma | 1 | 2022 | 529 | 0.550 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2022 | 541 | 0.550 |
Why?
|
| Length of Stay | 6 | 2024 | 1380 | 0.540 |
Why?
|
| Liver Neoplasms | 5 | 2023 | 1381 | 0.540 |
Why?
|
| Deafness | 1 | 2018 | 85 | 0.530 |
Why?
|
| Hospitals | 5 | 2023 | 438 | 0.530 |
Why?
|
| Aphasia, Primary Progressive | 3 | 2024 | 6 | 0.530 |
Why?
|
| Practice Patterns, Nurses' | 1 | 2017 | 11 | 0.530 |
Why?
|
| Motor Skills | 1 | 2017 | 82 | 0.530 |
Why?
|
| Aphasia | 1 | 2017 | 14 | 0.520 |
Why?
|
| Cochlear Implants | 1 | 2018 | 59 | 0.520 |
Why?
|
| Psychotherapy | 1 | 2020 | 247 | 0.520 |
Why?
|
| Enteral Nutrition | 2 | 2020 | 267 | 0.520 |
Why?
|
| Rectum | 2 | 2017 | 114 | 0.520 |
Why?
|
| Speech-Language Pathology | 3 | 2023 | 15 | 0.510 |
Why?
|
| Parkinson Disease | 2 | 2023 | 734 | 0.510 |
Why?
|
| Fractures, Bone | 1 | 2019 | 205 | 0.510 |
Why?
|
| Wounds, Penetrating | 1 | 2017 | 142 | 0.500 |
Why?
|
| Patient Selection | 3 | 2019 | 737 | 0.500 |
Why?
|
| Prospective Studies | 17 | 2024 | 6572 | 0.480 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2025 | 2169 | 0.470 |
Why?
|
| Postoperative Complications | 11 | 2023 | 3142 | 0.460 |
Why?
|
| Blood Component Transfusion | 7 | 2024 | 58 | 0.440 |
Why?
|
| Speech Therapy | 3 | 2024 | 15 | 0.430 |
Why?
|
| Colon | 1 | 2017 | 370 | 0.430 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2023 | 105 | 0.420 |
Why?
|
| Young Adult | 19 | 2025 | 9958 | 0.410 |
Why?
|
| Hemostasis | 1 | 2013 | 73 | 0.400 |
Why?
|
| Treatment Outcome | 20 | 2025 | 13034 | 0.390 |
Why?
|
| Time-to-Treatment | 3 | 2020 | 211 | 0.390 |
Why?
|
| Reproducibility of Results | 11 | 2023 | 3011 | 0.380 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2014 | 180 | 0.380 |
Why?
|
| Specialties, Surgical | 2 | 2024 | 91 | 0.380 |
Why?
|
| Cannula | 2 | 2024 | 31 | 0.380 |
Why?
|
| Catheterization | 2 | 2020 | 241 | 0.370 |
Why?
|
| Biliary Atresia | 2 | 2025 | 206 | 0.370 |
Why?
|
| Databases, Factual | 6 | 2019 | 1229 | 0.370 |
Why?
|
| Platelet Transfusion | 6 | 2022 | 56 | 0.370 |
Why?
|
| Pancreatic Ducts | 2 | 2024 | 22 | 0.370 |
Why?
|
| Hematopoiesis | 1 | 2013 | 224 | 0.360 |
Why?
|
| Sclerotherapy | 3 | 2006 | 39 | 0.360 |
Why?
|
| Voice Quality | 2 | 2020 | 22 | 0.360 |
Why?
|
| Aged | 16 | 2025 | 21438 | 0.350 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 669 | 0.350 |
Why?
|
| Incidence | 9 | 2023 | 3379 | 0.350 |
Why?
|
| Biomarkers | 5 | 2025 | 3407 | 0.340 |
Why?
|
| Risk Assessment | 10 | 2025 | 3739 | 0.340 |
Why?
|
| Societies, Medical | 5 | 2024 | 779 | 0.340 |
Why?
|
| Surveys and Questionnaires | 9 | 2024 | 4003 | 0.340 |
Why?
|
| Middle Aged | 20 | 2025 | 28998 | 0.330 |
Why?
|
| Vascular Neoplasms | 2 | 2011 | 33 | 0.330 |
Why?
|
| United States | 14 | 2024 | 11667 | 0.320 |
Why?
|
| Decision Support Techniques | 4 | 2018 | 310 | 0.320 |
Why?
|
| Apraxias | 2 | 2022 | 15 | 0.320 |
Why?
|
| Conservative Treatment | 2 | 2019 | 41 | 0.300 |
Why?
|
| Language Therapy | 2 | 2024 | 3 | 0.300 |
Why?
|
| Respiratory Insufficiency | 2 | 2024 | 245 | 0.300 |
Why?
|
| Amphetamine-Related Disorders | 2 | 2019 | 38 | 0.300 |
Why?
|
| Bacterial Infections | 1 | 2011 | 323 | 0.290 |
Why?
|
| Veins | 2 | 2006 | 104 | 0.290 |
Why?
|
| Cross Infection | 1 | 2011 | 342 | 0.290 |
Why?
|
| Colostomy | 2 | 2019 | 28 | 0.280 |
Why?
|
| Tissue Engineering | 3 | 2006 | 167 | 0.280 |
Why?
|
| Follow-Up Studies | 11 | 2023 | 5416 | 0.260 |
Why?
|
| Disease Progression | 4 | 2025 | 2225 | 0.260 |
Why?
|
| Phenotype | 5 | 2025 | 4528 | 0.250 |
Why?
|
| Anastomosis, Surgical | 2 | 2006 | 167 | 0.250 |
Why?
|
| Language Disorders | 2 | 2024 | 26 | 0.250 |
Why?
|
| Trachea | 2 | 2024 | 210 | 0.240 |
Why?
|
| Hydrogels | 2 | 2006 | 108 | 0.240 |
Why?
|
| Registries | 4 | 2023 | 1581 | 0.240 |
Why?
|
| Lymphangioma | 1 | 2006 | 24 | 0.240 |
Why?
|
| Echocardiography | 2 | 2024 | 1129 | 0.240 |
Why?
|
| Catheterization, Central Venous | 2 | 2018 | 139 | 0.240 |
Why?
|
| Esophageal Atresia | 1 | 2006 | 52 | 0.240 |
Why?
|
| Matrix Metalloproteinases | 1 | 2006 | 63 | 0.240 |
Why?
|
| Blood Vessels | 1 | 2006 | 103 | 0.240 |
Why?
|
| Genitalia, Female | 1 | 2006 | 46 | 0.240 |
Why?
|
| Severity of Illness Index | 4 | 2023 | 3092 | 0.240 |
Why?
|
| Cognition | 4 | 2025 | 811 | 0.240 |
Why?
|
| Time Factors | 7 | 2019 | 6448 | 0.240 |
Why?
|
| Genital Neoplasms, Female | 1 | 2006 | 46 | 0.240 |
Why?
|
| Ataxia Telangiectasia | 1 | 2025 | 14 | 0.240 |
Why?
|
| Fibroblasts | 3 | 2006 | 861 | 0.240 |
Why?
|
| Telangiectasis | 1 | 2005 | 10 | 0.240 |
Why?
|
| Self Report | 3 | 2023 | 549 | 0.230 |
Why?
|
| Memory, Episodic | 1 | 2025 | 28 | 0.230 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2025 | 19 | 0.230 |
Why?
|
| Emergency Medical Services | 2 | 2021 | 418 | 0.230 |
Why?
|
| Evidence-Based Medicine | 7 | 2022 | 663 | 0.230 |
Why?
|
| Spinal Neoplasms | 2 | 2022 | 75 | 0.230 |
Why?
|
| Aphasia, Broca | 1 | 2024 | 2 | 0.230 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 2140 | 0.230 |
Why?
|
| Iliac Artery | 1 | 2005 | 75 | 0.230 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2025 | 13 | 0.230 |
Why?
|
| Biomedical Technology | 1 | 2025 | 36 | 0.220 |
Why?
|
| Extracellular Matrix | 1 | 2006 | 237 | 0.220 |
Why?
|
| Hemangioma | 1 | 2006 | 97 | 0.220 |
Why?
|
| Surgical Procedures, Operative | 2 | 2019 | 223 | 0.220 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2025 | 60 | 0.220 |
Why?
|
| Failure to Rescue, Health Care | 2 | 2021 | 11 | 0.220 |
Why?
|
| Collagen | 1 | 2006 | 303 | 0.220 |
Why?
|
| Teratoma | 2 | 2022 | 132 | 0.220 |
Why?
|
| Acetylcysteine | 1 | 2025 | 82 | 0.220 |
Why?
|
| Esophagus | 1 | 2006 | 234 | 0.220 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2024 | 39 | 0.220 |
Why?
|
| Executive Function | 1 | 2025 | 126 | 0.220 |
Why?
|
| Mesons | 3 | 2014 | 7 | 0.210 |
Why?
|
| Memory, Short-Term | 1 | 2025 | 142 | 0.210 |
Why?
|
| Morpholines | 1 | 2024 | 67 | 0.210 |
Why?
|
| Molecular Chaperones | 1 | 2025 | 173 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2024 | 109 | 0.210 |
Why?
|
| Ostomy | 1 | 2023 | 11 | 0.210 |
Why?
|
| Smartphone | 1 | 2023 | 46 | 0.210 |
Why?
|
| Fetoscopy | 2 | 2024 | 448 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 3831 | 0.200 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2019 | 1342 | 0.200 |
Why?
|
| Linoleic Acid | 1 | 2022 | 17 | 0.200 |
Why?
|
| Brain Injuries | 1 | 2008 | 716 | 0.200 |
Why?
|
| Paraspinal Muscles | 1 | 2022 | 8 | 0.190 |
Why?
|
| Pyrroles | 1 | 2024 | 182 | 0.190 |
Why?
|
| Heart Defects, Congenital | 4 | 2024 | 1865 | 0.190 |
Why?
|
| Pancreatectomy | 2 | 2024 | 149 | 0.190 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2019 | 20 | 0.190 |
Why?
|
| Speech Intelligibility | 2 | 2020 | 6 | 0.190 |
Why?
|
| Primary Progressive Nonfluent Aphasia | 1 | 2022 | 1 | 0.190 |
Why?
|
| Membrane Glycoproteins | 1 | 2025 | 420 | 0.190 |
Why?
|
| Language Development | 2 | 2021 | 36 | 0.190 |
Why?
|
| Aged, 80 and over | 6 | 2025 | 7104 | 0.190 |
Why?
|
| Biomarkers, Tumor | 2 | 2022 | 1659 | 0.190 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2022 | 70 | 0.190 |
Why?
|
| Speech Articulation Tests | 2 | 2020 | 8 | 0.190 |
Why?
|
| Hemostatics | 1 | 2022 | 62 | 0.190 |
Why?
|
| Craniofacial Abnormalities | 1 | 2024 | 253 | 0.190 |
Why?
|
| Gallstones | 1 | 2022 | 20 | 0.190 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2022 | 147 | 0.180 |
Why?
|
| Hepatectomy | 2 | 2018 | 119 | 0.180 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2023 | 97 | 0.180 |
Why?
|
| Hospitals, Urban | 1 | 2022 | 97 | 0.180 |
Why?
|
| Pelvic Neoplasms | 1 | 2022 | 23 | 0.180 |
Why?
|
| Parenteral Nutrition | 2 | 2021 | 199 | 0.180 |
Why?
|
| Nerve Block | 1 | 2022 | 62 | 0.180 |
Why?
|
| Nursing Homes | 1 | 2022 | 97 | 0.180 |
Why?
|
| Intracranial Hemorrhages | 3 | 2022 | 81 | 0.180 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 324 | 0.180 |
Why?
|
| Liver | 4 | 2023 | 1796 | 0.170 |
Why?
|
| Aftercare | 2 | 2021 | 155 | 0.170 |
Why?
|
| Amyloidosis | 1 | 2022 | 74 | 0.170 |
Why?
|
| Chromosome Deletion | 1 | 2024 | 654 | 0.170 |
Why?
|
| Tertiary Care Centers | 1 | 2022 | 257 | 0.170 |
Why?
|
| Nervous System Diseases | 1 | 2025 | 408 | 0.170 |
Why?
|
| Age Factors | 3 | 2019 | 2916 | 0.170 |
Why?
|
| Models, Theoretical | 2 | 2014 | 390 | 0.170 |
Why?
|
| Magnets | 1 | 2020 | 23 | 0.170 |
Why?
|
| Thyroid Gland | 1 | 2021 | 104 | 0.170 |
Why?
|
| Short Bowel Syndrome | 1 | 2021 | 66 | 0.170 |
Why?
|
| Analgesics | 1 | 2021 | 127 | 0.170 |
Why?
|
| Pancreatitis | 1 | 2022 | 140 | 0.170 |
Why?
|
| Tachycardia, Ventricular | 1 | 2023 | 250 | 0.170 |
Why?
|
| Hospitals, Pediatric | 4 | 2021 | 777 | 0.170 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 136 | 0.170 |
Why?
|
| Acute Disease | 2 | 2014 | 1160 | 0.170 |
Why?
|
| Masks | 1 | 2020 | 40 | 0.170 |
Why?
|
| Esophageal Stenosis | 1 | 2020 | 46 | 0.170 |
Why?
|
| Blood Gas Analysis | 1 | 2020 | 88 | 0.160 |
Why?
|
| Surgery Department, Hospital | 1 | 2020 | 21 | 0.160 |
Why?
|
| Respiratory System Abnormalities | 1 | 2020 | 44 | 0.160 |
Why?
|
| Breathing Exercises | 1 | 2020 | 8 | 0.160 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 39 | 0.160 |
Why?
|
| United Kingdom | 1 | 2020 | 235 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 186 | 0.160 |
Why?
|
| Risk Factors | 9 | 2023 | 10946 | 0.160 |
Why?
|
| Music Therapy | 1 | 2020 | 8 | 0.160 |
Why?
|
| Antifibrinolytic Agents | 2 | 2021 | 49 | 0.160 |
Why?
|
| Bias | 1 | 2020 | 143 | 0.160 |
Why?
|
| Cerebellum | 1 | 2023 | 462 | 0.160 |
Why?
|
| Mitochondria | 1 | 2025 | 747 | 0.160 |
Why?
|
| Fluorouracil | 2 | 2019 | 138 | 0.160 |
Why?
|
| Shock | 1 | 2021 | 98 | 0.160 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 237 | 0.160 |
Why?
|
| Allied Health Personnel | 1 | 2020 | 73 | 0.160 |
Why?
|
| Tissue Adhesions | 1 | 2019 | 29 | 0.160 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 558 | 0.160 |
Why?
|
| Radiography, Abdominal | 1 | 2019 | 49 | 0.160 |
Why?
|
| Balloon Occlusion | 1 | 2020 | 48 | 0.160 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2019 | 15 | 0.150 |
Why?
|
| Psychotherapy, Group | 1 | 2020 | 59 | 0.150 |
Why?
|
| Foreign Bodies | 1 | 2020 | 110 | 0.150 |
Why?
|
| Shock, Septic | 1 | 2021 | 154 | 0.150 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 2322 | 0.150 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2022 | 248 | 0.150 |
Why?
|
| Colectomy | 1 | 2020 | 84 | 0.150 |
Why?
|
| Workers' Compensation | 1 | 2019 | 3 | 0.150 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2023 | 332 | 0.150 |
Why?
|
| Contusions | 1 | 2019 | 16 | 0.150 |
Why?
|
| Return to Work | 1 | 2019 | 12 | 0.150 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 3766 | 0.150 |
Why?
|
| Occupational Injuries | 1 | 2019 | 11 | 0.150 |
Why?
|
| Evoked Potentials, Motor | 1 | 2019 | 34 | 0.150 |
Why?
|
| Methamphetamine | 1 | 2019 | 50 | 0.150 |
Why?
|
| Seat Belts | 1 | 2019 | 24 | 0.150 |
Why?
|
| Heart Arrest | 1 | 2023 | 374 | 0.150 |
Why?
|
| Gastrointestinal Diseases | 2 | 2020 | 357 | 0.150 |
Why?
|
| Multiple Trauma | 1 | 2019 | 63 | 0.150 |
Why?
|
| Central Nervous System Stimulants | 1 | 2019 | 128 | 0.150 |
Why?
|
| Tachycardia | 1 | 2019 | 69 | 0.150 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2018 | 11 | 0.150 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 145 | 0.150 |
Why?
|
| Hemostasis, Surgical | 1 | 2018 | 36 | 0.150 |
Why?
|
| Ablation Techniques | 1 | 2018 | 31 | 0.150 |
Why?
|
| Glasgow Coma Scale | 1 | 2019 | 200 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2022 | 568 | 0.140 |
Why?
|
| Intestinal Obstruction | 1 | 2019 | 96 | 0.140 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 250 | 0.140 |
Why?
|
| Motor Cortex | 1 | 2019 | 83 | 0.140 |
Why?
|
| Survivorship | 1 | 2018 | 44 | 0.140 |
Why?
|
| Anti-Anxiety Agents | 1 | 2019 | 77 | 0.140 |
Why?
|
| Hand | 1 | 2019 | 106 | 0.140 |
Why?
|
| Hong Kong | 1 | 2018 | 15 | 0.140 |
Why?
|
| Inpatients | 1 | 2022 | 552 | 0.140 |
Why?
|
| Survival Analysis | 2 | 2018 | 1573 | 0.140 |
Why?
|
| Thoracotomy | 1 | 2019 | 110 | 0.140 |
Why?
|
| Psychometrics | 2 | 2022 | 686 | 0.140 |
Why?
|
| Herniorrhaphy | 1 | 2018 | 78 | 0.140 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2018 | 81 | 0.140 |
Why?
|
| Muscle Spasticity | 1 | 2018 | 61 | 0.140 |
Why?
|
| Lactose Tolerance Test | 1 | 2017 | 1 | 0.140 |
Why?
|
| Ultrasonography | 2 | 2025 | 988 | 0.140 |
Why?
|
| Drainage | 1 | 2019 | 264 | 0.140 |
Why?
|
| Brachytherapy | 1 | 2018 | 95 | 0.140 |
Why?
|
| Malnutrition | 1 | 2020 | 161 | 0.140 |
Why?
|
| DNA Polymerase gamma | 1 | 2017 | 18 | 0.140 |
Why?
|
| Europe | 1 | 2018 | 372 | 0.140 |
Why?
|
| Lung Injury | 1 | 2019 | 123 | 0.130 |
Why?
|
| Logistic Models | 4 | 2019 | 1839 | 0.130 |
Why?
|
| Intestine, Small | 1 | 2019 | 309 | 0.130 |
Why?
|
| Telemedicine | 1 | 2023 | 495 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 729 | 0.130 |
Why?
|
| Colitis, Ulcerative | 1 | 2020 | 217 | 0.130 |
Why?
|
| Cochlear Implantation | 1 | 2018 | 53 | 0.130 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2005 | 788 | 0.130 |
Why?
|
| Radiosurgery | 1 | 2018 | 147 | 0.130 |
Why?
|
| ROC Curve | 1 | 2019 | 601 | 0.130 |
Why?
|
| Critical Pathways | 1 | 2017 | 75 | 0.130 |
Why?
|
| Movement Disorders | 1 | 2019 | 223 | 0.130 |
Why?
|
| Intellectual Disability | 1 | 2024 | 1087 | 0.130 |
Why?
|
| Hospitalization | 5 | 2023 | 1900 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 299 | 0.130 |
Why?
|
| Unnecessary Procedures | 1 | 2017 | 60 | 0.130 |
Why?
|
| Fatty Liver | 1 | 2018 | 211 | 0.130 |
Why?
|
| Preoperative Care | 1 | 2019 | 368 | 0.130 |
Why?
|
| Comprehension | 1 | 2017 | 81 | 0.130 |
Why?
|
| Organoplatinum Compounds | 1 | 2016 | 32 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 333 | 0.120 |
Why?
|
| Stomach Neoplasms | 1 | 2022 | 566 | 0.120 |
Why?
|
| Organ Size | 1 | 2017 | 448 | 0.120 |
Why?
|
| Aorta | 1 | 2020 | 550 | 0.120 |
Why?
|
| Anesthesia | 1 | 2019 | 216 | 0.120 |
Why?
|
| Health Care Surveys | 1 | 2017 | 294 | 0.120 |
Why?
|
| Blood Preservation | 1 | 2016 | 30 | 0.120 |
Why?
|
| ABO Blood-Group System | 1 | 2016 | 66 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2021 | 1047 | 0.120 |
Why?
|
| Surgical Wound Infection | 2 | 2015 | 273 | 0.120 |
Why?
|
| Surgical Wound | 1 | 2015 | 22 | 0.120 |
Why?
|
| Research Design | 1 | 2020 | 742 | 0.120 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 104 | 0.120 |
Why?
|
| Linear Models | 2 | 2017 | 713 | 0.120 |
Why?
|
| Mitochondrial Diseases | 1 | 2017 | 147 | 0.120 |
Why?
|
| Survivors | 1 | 2018 | 354 | 0.120 |
Why?
|
| Decision Making | 1 | 2020 | 703 | 0.120 |
Why?
|
| Electrons | 2 | 2014 | 26 | 0.110 |
Why?
|
| Esophageal Neoplasms | 1 | 2019 | 387 | 0.110 |
Why?
|
| Precision Medicine | 1 | 2018 | 360 | 0.110 |
Why?
|
| Intraoperative Care | 1 | 2015 | 119 | 0.110 |
Why?
|
| Survival Rate | 3 | 2018 | 2194 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 380 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 391 | 0.110 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 1280 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 1303 | 0.110 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 414 | 0.110 |
Why?
|
| Liver Cirrhosis | 2 | 2018 | 898 | 0.110 |
Why?
|
| Genomics | 1 | 2022 | 1647 | 0.110 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 1362 | 0.110 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2019 | 1009 | 0.110 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 211 | 0.110 |
Why?
|
| Elementary Particles | 1 | 2014 | 14 | 0.110 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 480 | 0.110 |
Why?
|
| Quantum Theory | 1 | 2014 | 22 | 0.110 |
Why?
|
| Caregivers | 1 | 2020 | 595 | 0.110 |
Why?
|
| Cardiac Catheterization | 1 | 2018 | 664 | 0.110 |
Why?
|
| Vitamin K Deficiency Bleeding | 1 | 2013 | 4 | 0.110 |
Why?
|
| Cohort Studies | 5 | 2023 | 5168 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 767 | 0.110 |
Why?
|
| Vasoconstrictor Agents | 1 | 2014 | 141 | 0.100 |
Why?
|
| Benchmarking | 1 | 2014 | 138 | 0.100 |
Why?
|
| Canada | 3 | 2021 | 338 | 0.100 |
Why?
|
| Extracorporeal Circulation | 1 | 2013 | 55 | 0.100 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2013 | 66 | 0.100 |
Why?
|
| Hepatitis C, Chronic | 1 | 2017 | 370 | 0.100 |
Why?
|
| Jugular Veins | 2 | 2020 | 75 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 762 | 0.100 |
Why?
|
| Shock, Traumatic | 2 | 2022 | 7 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2022 | 1176 | 0.100 |
Why?
|
| Nuclear Physics | 1 | 2012 | 17 | 0.100 |
Why?
|
| Mass Screening | 1 | 2018 | 830 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 1035 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 235 | 0.090 |
Why?
|
| Spectrum Analysis | 1 | 2012 | 66 | 0.090 |
Why?
|
| Anxiety | 1 | 2019 | 994 | 0.090 |
Why?
|
| Asia | 2 | 2024 | 126 | 0.090 |
Why?
|
| Patient Admission | 1 | 2013 | 185 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2017 | 822 | 0.090 |
Why?
|
| Protons | 1 | 2012 | 98 | 0.090 |
Why?
|
| Sertraline | 1 | 2012 | 45 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1826 | 0.090 |
Why?
|
| Physics | 1 | 2011 | 8 | 0.090 |
Why?
|
| Equipment Contamination | 1 | 2011 | 41 | 0.090 |
Why?
|
| Genital Neoplasms, Male | 1 | 2011 | 12 | 0.090 |
Why?
|
| Genitalia, Male | 1 | 2011 | 35 | 0.090 |
Why?
|
| Pregnancy | 5 | 2024 | 7555 | 0.090 |
Why?
|
| Rabbits | 3 | 2006 | 673 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2023 | 824 | 0.080 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 128 | 0.080 |
Why?
|
| Research | 2 | 2022 | 265 | 0.080 |
Why?
|
| Neoplasms | 2 | 2021 | 2957 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1538 | 0.080 |
Why?
|
| Catheter-Related Infections | 1 | 2011 | 136 | 0.080 |
Why?
|
| Prognosis | 3 | 2017 | 5014 | 0.080 |
Why?
|
| Hemispherectomy | 1 | 2010 | 26 | 0.080 |
Why?
|
| Nitric Oxide | 2 | 2023 | 471 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 632 | 0.080 |
Why?
|
| Vascular Malformations | 1 | 2011 | 112 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2018 | 1103 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1439 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 2012 | 327 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2009 | 321 | 0.080 |
Why?
|
| Intestines | 2 | 2023 | 604 | 0.070 |
Why?
|
| Prenatal Diagnosis | 2 | 2019 | 629 | 0.070 |
Why?
|
| Patient Discharge | 2 | 2023 | 512 | 0.070 |
Why?
|
| Cleft Lip | 1 | 2009 | 135 | 0.070 |
Why?
|
| Cleft Palate | 1 | 2009 | 154 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 1952 | 0.070 |
Why?
|
| Neuropsychological Tests | 2 | 2025 | 991 | 0.070 |
Why?
|
| Stroke | 1 | 2015 | 1085 | 0.070 |
Why?
|
| Hemodiafiltration | 1 | 2007 | 18 | 0.070 |
Why?
|
| Rectal Prolapse | 1 | 2006 | 6 | 0.070 |
Why?
|
| Surgical Stapling | 1 | 2006 | 17 | 0.060 |
Why?
|
| Perineum | 1 | 2006 | 48 | 0.060 |
Why?
|
| Spinal Fractures | 1 | 2007 | 47 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2023 | 1444 | 0.060 |
Why?
|
| Lumbar Vertebrae | 1 | 2007 | 113 | 0.060 |
Why?
|
| Injections | 1 | 2006 | 152 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2019 | 959 | 0.060 |
Why?
|
| Osteoporosis | 1 | 2007 | 136 | 0.060 |
Why?
|
| Sclerosing Solutions | 1 | 2005 | 12 | 0.060 |
Why?
|
| Pulse | 1 | 2005 | 27 | 0.060 |
Why?
|
| Lymphatic System | 1 | 2005 | 19 | 0.060 |
Why?
|
| Prevalence | 2 | 2024 | 2658 | 0.060 |
Why?
|
| Intermittent Claudication | 1 | 2005 | 60 | 0.060 |
Why?
|
| Arteriovenous Malformations | 1 | 2005 | 48 | 0.060 |
Why?
|
| Independent Living | 1 | 2025 | 70 | 0.060 |
Why?
|
| Qualitative Research | 2 | 2019 | 669 | 0.060 |
Why?
|
| Administration, Intravenous | 1 | 2025 | 162 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2007 | 339 | 0.050 |
Why?
|
| Accreditation | 1 | 2024 | 93 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2022 | 1658 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2005 | 236 | 0.050 |
Why?
|
| Cervical Vertebrae | 1 | 2005 | 117 | 0.050 |
Why?
|
| Airway Management | 1 | 2024 | 66 | 0.050 |
Why?
|
| Perioperative Period | 1 | 2024 | 52 | 0.050 |
Why?
|
| Pandemics | 2 | 2023 | 1183 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2024 | 30 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2006 | 227 | 0.050 |
Why?
|
| Intelligence | 1 | 2024 | 108 | 0.050 |
Why?
|
| Airway Obstruction | 1 | 2005 | 167 | 0.050 |
Why?
|
| Gastroschisis | 1 | 2003 | 57 | 0.050 |
Why?
|
| Thoracoscopy | 1 | 2003 | 43 | 0.050 |
Why?
|
| Linoleic Acids | 1 | 2022 | 5 | 0.050 |
Why?
|
| Depression | 1 | 2012 | 1342 | 0.050 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2003 | 88 | 0.050 |
Why?
|
| Portal Vein | 1 | 2003 | 88 | 0.050 |
Why?
|
| Sildenafil Citrate | 1 | 2022 | 57 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2023 | 190 | 0.050 |
Why?
|
| Vena Cava, Inferior | 1 | 2003 | 105 | 0.050 |
Why?
|
| Triglycerides | 1 | 2025 | 617 | 0.050 |
Why?
|
| Recurrence | 2 | 2022 | 1469 | 0.050 |
Why?
|
| Morbidity | 1 | 2023 | 256 | 0.050 |
Why?
|
| Texas | 2 | 2023 | 3629 | 0.050 |
Why?
|
| Blood Loss, Surgical | 1 | 2003 | 159 | 0.050 |
Why?
|
| Autopsy | 1 | 2022 | 114 | 0.050 |
Why?
|
| Spleen | 1 | 2023 | 270 | 0.050 |
Why?
|
| Epilepsy | 1 | 2010 | 889 | 0.050 |
Why?
|
| Birth Weight | 1 | 2023 | 350 | 0.050 |
Why?
|
| Data Collection | 1 | 2023 | 391 | 0.050 |
Why?
|
| Propensity Score | 1 | 2023 | 257 | 0.050 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2021 | 88 | 0.050 |
Why?
|
| Cholecystectomy | 1 | 2022 | 64 | 0.040 |
Why?
|
| Fluid Therapy | 1 | 2022 | 147 | 0.040 |
Why?
|
| Italy | 1 | 2021 | 131 | 0.040 |
Why?
|
| Atrophy | 1 | 2022 | 252 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2023 | 402 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 2024 | 289 | 0.040 |
Why?
|
| Operating Rooms | 1 | 2022 | 79 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 309 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2021 | 102 | 0.040 |
Why?
|
| Walking | 1 | 2022 | 234 | 0.040 |
Why?
|
| Longevity | 1 | 2022 | 160 | 0.040 |
Why?
|
| Databases as Topic | 1 | 2020 | 76 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2020 | 29 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 381 | 0.040 |
Why?
|
| Triazines | 1 | 2020 | 33 | 0.040 |
Why?
|
| Malaysia | 1 | 2019 | 17 | 0.040 |
Why?
|
| Recreation | 1 | 2020 | 20 | 0.040 |
Why?
|
| Appendectomy | 1 | 2020 | 92 | 0.040 |
Why?
|
| Taiwan | 1 | 2019 | 62 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2021 | 341 | 0.040 |
Why?
|
| Republic of Korea | 1 | 2019 | 53 | 0.040 |
Why?
|
| Brain | 2 | 2023 | 3176 | 0.040 |
Why?
|
| Acute Kidney Injury | 1 | 2007 | 672 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 266 | 0.040 |
Why?
|
| Benzamides | 1 | 2020 | 124 | 0.040 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2022 | 373 | 0.040 |
Why?
|
| International Cooperation | 1 | 2020 | 165 | 0.040 |
Why?
|
| Japan | 1 | 2019 | 157 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 272 | 0.040 |
Why?
|
| Interdisciplinary Communication | 1 | 2020 | 133 | 0.040 |
Why?
|
| Shock, Cardiogenic | 1 | 2021 | 178 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2023 | 489 | 0.040 |
Why?
|
| Curriculum | 1 | 2024 | 772 | 0.040 |
Why?
|
| Thrombosis | 1 | 2024 | 524 | 0.040 |
Why?
|
| India | 1 | 2019 | 238 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2019 | 98 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2022 | 237 | 0.040 |
Why?
|
| China | 1 | 2019 | 290 | 0.040 |
Why?
|
| Anorectal Malformations | 1 | 2019 | 15 | 0.040 |
Why?
|
| Contraindications, Procedure | 1 | 2018 | 4 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1163 | 0.040 |
Why?
|
| Erythrocyte Count | 1 | 2018 | 24 | 0.040 |
Why?
|
| Imidazoles | 1 | 2020 | 219 | 0.040 |
Why?
|
| Contraindications | 1 | 2018 | 79 | 0.040 |
Why?
|
| Ventilators, Mechanical | 1 | 2018 | 40 | 0.040 |
Why?
|
| Electromyography | 1 | 2019 | 141 | 0.040 |
Why?
|
| Medical Futility | 1 | 2018 | 38 | 0.040 |
Why?
|
| Eating | 1 | 2020 | 381 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2024 | 555 | 0.040 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2019 | 80 | 0.040 |
Why?
|
| Cisplatin | 1 | 2019 | 282 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2019 | 292 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2012 | 795 | 0.030 |
Why?
|
| Algorithms | 2 | 2015 | 1722 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2022 | 935 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2020 | 294 | 0.030 |
Why?
|
| Mortality | 1 | 2019 | 268 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2003 | 523 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 854 | 0.030 |
Why?
|
| Child Language | 1 | 2017 | 33 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2017 | 89 | 0.030 |
Why?
|
| Inflammation | 1 | 2005 | 1519 | 0.030 |
Why?
|
| Temperament | 1 | 2017 | 32 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2019 | 231 | 0.030 |
Why?
|
| Angiography | 1 | 2017 | 208 | 0.030 |
Why?
|
| Energy Intake | 1 | 2020 | 493 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2021 | 572 | 0.030 |
Why?
|
| Mutation | 2 | 2021 | 6228 | 0.030 |
Why?
|
| Animals | 4 | 2023 | 34798 | 0.030 |
Why?
|
| Subclavian Vein | 1 | 2016 | 21 | 0.030 |
Why?
|
| Laparotomy | 1 | 2017 | 144 | 0.030 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2022 | 560 | 0.030 |
Why?
|
| Leucovorin | 1 | 2016 | 54 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2017 | 272 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2018 | 589 | 0.030 |
Why?
|
| Eye Movements | 1 | 2015 | 78 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2017 | 223 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2015 | 192 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 1170 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1224 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 902 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 719 | 0.030 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 276 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2015 | 491 | 0.020 |
Why?
|
| Stents | 1 | 2019 | 869 | 0.020 |
Why?
|
| Particle Accelerators | 1 | 2012 | 3 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 1611 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2395 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1500 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3416 | 0.020 |
Why?
|
| Parents | 1 | 2017 | 1079 | 0.020 |
Why?
|
| Hemiplegia | 1 | 2010 | 43 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2011 | 209 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 697 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 462 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 1294 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 280 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2014 | 800 | 0.020 |
Why?
|
| Alendronate | 1 | 2007 | 21 | 0.020 |
Why?
|
| Respiration Disorders | 1 | 2007 | 33 | 0.020 |
Why?
|
| Defecation | 1 | 2006 | 34 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2007 | 56 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3351 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 18466 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2007 | 138 | 0.020 |
Why?
|
| Safety | 1 | 2006 | 216 | 0.020 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2005 | 28 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 247 | 0.010 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2005 | 53 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2005 | 286 | 0.010 |
Why?
|
| Bone Density | 1 | 2007 | 367 | 0.010 |
Why?
|
| Ethanol | 1 | 2005 | 164 | 0.010 |
Why?
|
| Cicatrix | 1 | 2005 | 126 | 0.010 |
Why?
|
| Constriction | 1 | 2003 | 47 | 0.010 |
Why?
|
| Face | 1 | 2005 | 188 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2005 | 635 | 0.010 |
Why?
|
| Biopsy | 1 | 2003 | 1284 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 4685 | 0.010 |
Why?
|